Aprea Therapeutics, Inc.: cashflow_operating
| Value | {"amount": -3631163, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-03-31 |
| Status | current |
| Entity | Aprea Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:02:26.698441+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/739522c8-f729-4874-b4f1-f541f78ab698
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-25-007667Retrieved: 2026-08-19T18:02:26.698441+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001781983/cashflow-operating/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/739522c8-f729-4874-b4f1-f541f78ab698
History
- no predecessors — first report